Novartis Acquires HDAC6 Inhibitor CKD-510 from CKD Pharmaceutical in a $1.31 Billion Deal
Swiss pharmaceutical major Novartis (NYSE: NVS) announced last week that it has struck a deal...
China’s NMPA Accepts EOC Pharma Group’s Filing for Vascepa (Icosapent Ethyl) for Review
The China-based EOC Pharma Group has achieved a significant milestone with the National Medical Products...
Eli Lilly Clears Final Regulatory Hurdle with NRC Approval for Point Biopharma Acquisition
The Nuclear Regulatory Commission (NRC) of the US has given its approval for the transfer...
Merck KGaA Outlines Expansion Plans for US Healthcare Market with Anticipated 2025 Drug Launches
Germany’s Merck KGaA (ETR: MRK), a leading player in the global pharmaceutical industry, has this...
Hubei Topgene Biotechnology and Shanghai Genechem Partner on Drug Toxicological Safety and Clinical Research
Hubei Topgene Biotechnology Co., Ltd, a China-based biotechnology company, has entered into a partnership with...
EMA’s CHMP Issues Positive Opinion for Roche’s Tecentriq SC Subcutaneous Formulation
The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA)...
PRECEDO Secures Over RMB 100 Million in Financing to Build Living Primary Cancer Cell Bank
PRECEDO, a leading cell engineering specialist headquartered in Hefei, has reportedly secured more than RMB...
Yantai Dongcheng Pharmaceutical and Eckert & Ziegler Form Joint Venture for Medical Isotopes
Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675), a China-based pharmaceutical company, is poised to...
China’s National Allied Procurement Office Announces VBP Tender for Medical Consumables and 3D Printing Products
The National Allied Procurement Office has released a notification outlining plans for a volume-based procurement...
Sansure Biotech Secures CE IVDR Certifications for Chemiluminescence Analyzers in the EU
China-based molecular diagnostics specialist, Sansure Biotech Inc., (SHA: 688289), has announced that it has received...
Huadong Medicine Co., Ltd Secures Partnership and Commercial Rights for Yuyan’s Botulinum Toxin
China-based Huadong Medicine Co., Ltd (SHE: 000963) has entered into an equity investment and partnership...
Zeiss Group and China’s Healthcare Cloud Collaborate on Ophthalmic Services in China
Germany-based Zeiss Group, a leader in optical systems and optoelectronic product manufacturing, has entered into...
Eli Lilly’s Donanemab on Track for Priority Review in China for Early-Stage Alzheimer’s
The China’s Center for Drug Evaluation (CDE) website has indicated that Eli Lilly’s (NYSE: LLY)...
CASI Pharmaceuticals Reports Q3 2023 Results with Mixed Fortunes and Positive Developments
China-based CASI Pharmaceuticals Inc., (NASDAQ: CASI) has unveiled its financial results for the third quarter...
Novartis Pharma AG Partners with Legend Biotech Corp. for CAR-T Therapies in $1.1 Billion Deal
China-based Legend Biotech Corp., (NASDAQ: LEGN) has secured a second multinational partnership for its chimeric...
Nona Biosciences Partners with GeneQuantum Healthcare to Advance Drug Conjugate Discovery
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), which operates across the...
Autobio Diagnostics Expands Strategic Partnership with Guorun Medical Supply Chain Services
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with Guorun Medical...
BMS Secures ORM-6151 for Acute Myeloid Leukemia Treatment with Orum Therapeutics Deal
Bristol Myers Squibb (BMS; NYSE: BMY) has made a significant move in the field of...
Bayer Withdraws Aliqopa FDA Filing Following Missed Phase III Endpoint
Germany-based pharmaceutical major Bayer (ETR: BAYN) has announced its decision to withdraw the filing for...
Boehringer Ingelheim and Scottish Enterprise Co-Lead GBP 4.3M Seed Funding for Glox Therapeutics
Germany’s Boehringer Ingelheim, in collaboration with Scotland’s national economic development agency Scottish Enterprise, has co-led...